NCT02136498

My Mobile Advice Program: A Randomized Pilot Feasibility Study

Internet-based Medication Adherence Program for Nicotine Dependence Treatment

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Kaiser Permanente · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).

Detailed description

Investigators will develop and pilot test a prototype of the MyMAP intervention.The intervention is designed to help smokers better manage issues known to reduce treatment adherence (withdrawal symptoms, medication side-effects, low motivation, and inadequate behavioral skills for medication adherence) and to facilitate greater communication between patients and providers so clinicians can provide appropriate oversight of medication use, intervene when medically necessary, and address patient concerns that may otherwise lead to non-adherence or early treatment termination.

Conditions

• Smoking Cessation
• Medication Adherence

Interventions

Type	Name	Description
DRUG	Varenicline	Standard 12 week course of varenicline, provided in both arms
BEHAVIORAL	Cognitive-behavioral self-help	Standard self-help education for smoking cessation, delivered via mobile-optimized website accessible via smartphone.
BEHAVIORAL	MyMAP (My Mobile Advice Program)	Same standard self-help intervention as in control arm + automatically-tailored support and advice for managing nicotine withdrawal symptoms + secure messaging with cessation counselor

Timeline

• Start date: 2014-10-01
• Primary completion: 2016-02-01
• Completion: 2016-02-01
• First posted: 2014-05-13
• Last updated: 2017-11-13
• Results posted: 2016-10-10

Locations

1 site across 1 country: United States